子宫内膜癌淋巴血管间隙浸润的半定量评估:预后与临床意义
这项回顾性多中心研究纳入1258例子宫内膜癌患者,按三级评分系统(无、局灶、弥漫)半定量评估LVSI。弥漫性LVSI是淋巴结转移和远处复发的独立危险因素,且与OS和DFS显著降低相关;辅助放疗可改善弥漫性LVSI患者的生存,与分级、组织学类型和淋巴结转移状态无关。
要点
- 弥漫性LVSI是淋巴结转移和远处复发的独立危险因素。
- 弥漫性LVSI患者远处复发率高于局灶性和无LVSI患者。
- 辅助放疗可改善弥漫性LVSI患者的OS和DFS。
核心结论
- 弥漫性LVSI是子宫内膜癌患者淋巴结转移和远处复发的独立危险因素,并与OS和DFS显著降低相关。
- 在弥漫性LVSI女性中,辅助放疗可改善生存,与分级、组织学类型和淋巴结转移状态无关。
研究设计与样本
- 回顾性多中心研究,纳入经组织学确诊的子宫内膜癌手术分期患者共1258例。
- LVSI按三级评分系统(无、局灶、弥漫)进行半定量评估。
主要发现
- 1258例患者中LVSI发生率为32.8%(n=412),其中局灶性12.7%(n=160)、弥漫性20%(n=252)。
- 淋巴结转移率从无LVSI的5%升至局灶性LVSI的15%和弥漫性LVSI的33%(p<0.001)。
- 远处复发在弥漫性LVSI患者中更常见,弥漫性、局灶性和无LVSI分别为24.9%、14.7%和6.6%(p<0.001)。
- 弥漫性LVSI显著增加远处转移风险(校正比值比2.57,p<0.001)。
关键数值与推荐
- LVSI半定量采用三级评分系统:无、局灶和弥漫。
- 辅助放疗与弥漫性LVSI患者OS和DFS改善相关。
临床怎么用
- 对子宫内膜癌病理报告中的LVSI应进行半定量分级(无、局灶、弥漫),而非仅报告有无。
- 弥漫性LVSI患者淋巴结转移和远处复发风险高,可考虑辅助放疗以改善生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The interpretation of lymph-vascular space invasion (LVSI) is usually qualitative, as presence or absence. The aim of this study is to investigate the prognostic role of LVSI in patients affected by endometrial cancer, when evaluated with a semiquantitative analysis. METHODS: This retrospective multicentre study enrolled patients who received a histologically confirmed diagnosis of endometrial cancer. The assessment of LVSI was semiquantitative in accordance with the three-tiered scoring system (absent, focal and diffuse). RESULTS: Among 1258 patients with surgical-stage endometrial cancer, LVSI has been found in 32.8% of cases (n = 412), whose 12.7% (n = 160) were focal, and 20% (n = 252) diffuse. The rate of lymph node metastasis increased from the 5% in patients with no LVSI to 15% in patients with focal LVSI and 33% in those with diffuse LVSI (p < 0.001). Distant recurrences were more frequent in patients with diffuse LVSI than in focal or no LVSI (24.9% versus 14.7% and 6.6%, respectively, p < 0.001). Diffuse LVSI was found to significantly increase the risk of distant metastasis (adjusted odds ratio (A OR) 2.57, p < 0.001). Adjuvant radiation were associated with improved overall survival (OS) and disease-free survival (DFS) in patients with diffuse LVSI. CONCLUSION: The presence of diffuse LVSI is an independent risk factor for both lymph node metastasis and distant recurrence in endometrial cancer patients, and it is associated with a significantly decreased OS and DFS. Adjuvant radiation improved survival regardless of grading, histotype and lymph nodal metastasis in women with diffuse LVSI.
引用
- Restaino S, Tortorella L, Dinoi G, et al. Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications. Eur J Cancer. 2020. PMID: 33217679. doi:10.1016/j.ejca.2020.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。